HCWC vs BTMD vs HIMS vs OPRX vs DOCS

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -2. 5% for biote Corp. (BTMD). biote Corp. (BTMD) offers the better valuation at 2. 9x trailing P/E, making it the more compelling value choice. Analysts rate OptimizeRx Corporation (OPRX) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, biote Corp.

(BTMD) is the cheapest at 2. 9x versus Hims & Hers Health, Inc. at 55. 4x. On forward P/E, OptimizeRx Corporation is actually cheaper at 6. 8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +173. 9%, compared to -94. 5% for Healthy Choice Wellness Corp. (HCWC). Over 10 years, the gap is even starker: HIMS returned +188. 5% versus HCWC's -94. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Doximity, Inc.

(DOCS) is the lower-risk stock at 0. 99β versus Hims & Hers Health, Inc. 's 2. 48β — meaning HIMS is approximately 150% more volatile than DOCS relative to the S&P 500. On balance sheet safety, Doximity, Inc. (DOCS) carries a lower debt/equity ratio of 1% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -2. 5% for biote Corp. (BTMD). On earnings-per-share growth, the picture is similar: biote Corp. grew EPS 703. 5% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Doximity, Inc.

(DOCS) is the more profitable company, earning 39. 1% net margin versus -5. 0% for Healthy Choice Wellness Corp. — meaning it keeps 39. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOCS leads at 39. 9% versus -3. 2% for HCWC. At the gross margin level — before operating expenses — DOCS leads at 90. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, OptimizeRx Corporation (OPRX) trades at 6.

8x forward P/E versus 58. 3x for Hims & Hers Health, Inc. — 51. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPRX: 164. 0% to $17. 00.

In this comparison, BTMD (2.

2% yield) pays a dividend. HCWC, HIMS, OPRX, DOCS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Doximity, Inc.

(DOCS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 99)). OptimizeRx Corporation (OPRX) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DOCS: -51. 0%, OPRX: +104. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HCWC (Consumer Defensive) and BTMD (Healthcare) and HIMS (Healthcare) and OPRX (Healthcare) and DOCS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HCWC is a small-cap quality compounder stock; BTMD is a small-cap deep-value stock; HIMS is a small-cap high-growth stock; OPRX is a small-cap high-growth stock; DOCS is a small-cap high-growth stock. BTMD pays a dividend while HCWC, HIMS, OPRX, DOCS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.